Sulcardine Sulfate

硫酸舒欣啶

Report date: 2024/12/18 16:33:45
NME

Base Information

Drug NameSulcardine Sulfate
Drug Alias Name硫酸舒欣啶注射液Sulcardine sulphate舒欣啶HBI-3000B-87823
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersVoltage-gated calcium channel blockersSodium channels blockers
TargetsPotassium channelVoltage-gated calcium channelSodium channels
Therapy Area/IndicationsAtrial FibrillationArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBosnia and HerzegovinaCanadaUnited States +[7] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of SciencesYangzhou Zhongbao Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHuyabio International LLCYangzhou Zhongbao Pharmaceutical Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsAtrial FibrillationArrhythmias, Cardiac
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia